Resistance to ABT-737 in activated T lymphocytes: molecular mechanisms and reversibility by inhibition of the calcineurin–NFAT pathway

Pietro E. Cippà(University of Basel), Thomas Fehr(University Hospital of Zurich)

Cell Death and Disease

April 19, 2012

10.1038/cddis.2012.38

Cited by 23

Related Papers

Myeloma Responses and Tolerance Following Combined Kidney and Nonmyeloablative Marrow Transplantation: In Vivo and In Vitro Analyses

|American Journal of Transplantation|2006|260

Daratumumab for relapsed or refractory AL amyloidosis with high plasma cell burden

|Hematological Oncology|2019|34

Targeting apoptosis to induce stable mixed hematopoietic chimerism and long-term allograft survival without myelosuppressive conditioning in mice

|Blood|2013|25

Distinctive Expression of Bcl-2 Factors in Regulatory T Cells Determines a Pharmacological Target to Induce Immunological Tolerance

|Frontiers in Immunology|2016|20

Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology

|Pathology International|2012|14